Abstract:Jyoti Rajan Sharma, 1, &ast Hannah Fokkens, 1, 2, &ast Ria Laubscher, 3 Teke Ruffin Apalata, 4 Sibusiso Cyprian Nomatshila, 5 Samuel Yao Alomatu, 6 Hans Strijdom, 2 Rabia Johnson 1, 2 1 Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa; 2 Centre for Cardiometabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; 3 Biostatistics Research Unit, South African Medical Research Council, Cape Town, South Africa; 4 Department of Laboratory-Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University and National Health Laboratory Services, Mthatha, South Africa; 5 Department of Public Health, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha, South Africa; 6 Department of Internal Medicine, Nelson Mandela Central Hospital and Walter Sisulu University, Mthatha, South Africa &astThese authors contributed equally to this work Correspondence: Rabia Johnson, Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, Cape Town, South Africa, Email Purpose: Hypertension is a leading cause of cardiovascular-related morbidity and mortality worldwide, with a prevalence increasing at an alarming rate in both middle- and low-income countries. Various environmental and genetic factors have been attributed to play a significant role in the increasing prevalence of hypertension. Single nucleotide polymorphisms (SNPs) in the angiotensinogen ( AGT ) gene are reported to have a significant association with hypertension; however, there are limited studies done on South African populations. Therefore, this case–control study aimed to investigate the association between AGT SNPs (rs2004776, rs3789678, rs5051 and rs7079) with hypertension in a study population of isiXhosa-speaking participants from the Eastern Cape Province in South Africa. Materials and Methods: The SNPs were genotyped in 250 hypertensive cases and 237 normotensive controls, using TaqMan genotyping assays. Results: For the SNP rs2004776, the frequency of CC genotype (18.4%) and C allele (44%) in hypertensive cases showed no significant differences (p = 0.52, χ 2 = 1.32), when compared to the normotensive control group (CC: 19.8% and C allele: 43%). Similar results were obtained for the genotypic and allelic frequencies between hypertensive cases and normotensive controls for rs3789678 (p = 0.88, χ 2=0.26) and rs5051 (p = 0.57, χ 2=1.12), and rs7079 (p = 0.33, χ 2=2.23). These findings demonstrate that there were no significant associations between the SNPs rs2004776, rs3789678, rs7079, rs5051 with hypertension in our study population. Conclusion: These findings suggest that AGT gene polymorphisms are not associated with the development of hypertension in the studied population. The present study represents the first genetic report to investigate the AGT gene polymorphisms with hypertension in an isiXhosa-speaking South African population. Keywords: hypertension, gene, ACE, AGT, polymorphism Cardiovascular diseases (CVD) are the leading cause of deaths globally, accounting for 19.8 million deaths worldwide in 2022. 1–3 Hypertension drives the global burden of CVD and is a leading cause of cardiovascular-related mortality worldwide, with 1.39 billion affected adults and 10.4 million deaths globally. 4–6 It has emerged as a major public health issue in sub-Saharan Africa, contributing to the region's rising number of early deaths. In South Africa, hypertension has an estimated prevalence of 27–58% and is referred as a "silent killer", with 46% of adults being oblivious of their hypertension status. 7–11 The prevalence of hypertension in the rural communities is even higher. According to Sharma et al, 12 the prevalence of hypertension is 71% in the rural community of Mthatha town in Eastern Cape province, South Africa. Previously, other studies have also highlighted the serious concern of escalating prevalence of hypertension in rural South Africa. 13–15 Despite having an advanced understanding of the pathogenesis and the management of hypertension, there is still a progressive rise in its prevalence. 16 Various factors, including environmental and genetic factors, have been attributed to play a significant role in the increasing prevalence of hypertension. 12,17–19 Although the exact role of the genetic factors in the regulation of hypertension is still unkn -Abstract Truncated-

Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans

Hypertension in African Populations: Review and Computational Insights

Genetic Factors Contributing to the Pathogenesis of Essential Hypertension in Two African Populations

No Association Between AGT Gene Polymorphisms with Hypertension in a South African Population

AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis

mRNA expression profile in peripheral blood mononuclear cells based on ADRB1 Ser49Gly and Arg389Gly polymorphisms in essential hypertension — a case-control pilot investigation in South Indian population

Mdr1 Pharmacogenetics: Frequency of the C3435t Mutation in Exon 26 is Significantly Influenced by Ethnicity

Prevalence of IGFBP3, NOS3 and TCF7L2 polymorphisms and their association with hypertension: a population-based study with Brazilian women of African descent

A Genome-Wide Association Study of Hypertension and Blood Pressure in African Americans

Abstract 8: Polygenic Resistance to Blood Pressure Treatment and Stroke Risk

A46G AND C79G POLYMORPHISMS IN BETA2-ADRENERGIC RECEPTOR GENE (ADRB2) AND ESSENTIAL HYPERTENSION RISK: A META-ANALYSIS: PP.21.327

Genetic Variations in CYP17A1, CACNB2 and PLEKHA7 Are Associated with Blood Pressure And/or Hypertension in She Ethnic Minority of China.

Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis.

Two Polymorphisms in NEDD4L Gene and Essential Hypertension in Chinese Hans - a Population-Based Case-Control Study.

Rare coding variants in RCN3 are associated with blood pressure

Abstract 040: Comparative Genomic Analysis and Functional Insights for Blood Pressure-Associated Single Nucleotide Polymorphisms

Abstract 076: the Blood Pressure-associated Non-coding Single Nucleotide Polymorphism Rs28451064 Influences Gene Expression in Human Endothelial Cells

Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment.

Meta-Analysis and Multivariate GWAS Analyses in 80,950 Individuals of African Ancestry Identify Novel Variants Associated with Blood Pressure Traits

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals

Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension